Evidence map›Paper›PMID 42029569›Full record

ReviewMuscles (Basel, Switzerland)2026

Revisiting Myositis Ossificans: A Comprehensive Stage-by-Stage Imaging Review.

Consolato Gullì, Giuseppe Ferrara, Emanuele Ferravante, Roberto Calbi, Mario Di Diego, Davide Parisi, Daniele Perla, Tommaso Villa, Luigi Natale

Abstract readReview
In one paragraph

Review in Muscles (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Consolato GullìAdvanced Radiology Center, Department of Diagnostic Imaging and Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00136 Rome, Italy.ORCID 0000-0001-6035-8774
Giuseppe FerraraSection of Radiology, Department of Radiological and Hematological Sciences, Università Cattolica del Sacro Cuore, 00136 Rome, Italy.ORCID 0009-0008-9247-4372
Emanuele FerravanteSection of Radiology, Department of Radiological and Hematological Sciences, Università Cattolica del Sacro Cuore, 00136 Rome, Italy.
Roberto CalbiDepartment of Radiology, Ospedale Regionale Miulli, 70021 Bari, Italy.ORCID 0000-0003-0934-8890
Mario Di DiegoAdvanced Radiology Center, Department of Diagnostic Imaging and Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00136 Rome, Italy.
Davide ParisiSection of Radiology, Department of Radiological and Hematological Sciences, Università Cattolica del Sacro Cuore, 00136 Rome, Italy.
Daniele PerlaAdvanced Radiology Center, Department of Diagnostic Imaging and Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00136 Rome, Italy.ORCID 0009-0008-5099-2024
Tommaso VillaSection of Radiology, Department of Radiological and Hematological Sciences, Università Cattolica del Sacro Cuore, 00136 Rome, Italy.
Luigi NataleAdvanced Radiology Center, Department of Diagnostic Imaging and Radiation Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00136 Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myositis ossificans (MO) is a benign, self-limiting heterotopic ossification process that typically develops within soft tissues following trauma, although non-traumatic forms have also been described. Despite its benign nature, MO frequently represents a diagnostic challenge, particularly in its early stages when imaging findings may mimic aggressive soft-tissue tumors, leading to unnecessary biopsies or surgical interventions. This narrative review provides an updated overview of the classification, pathophysiology, and imaging features of myositis ossificans, with a specific focus on the time-dependent evolution of radiologic appearances across different imaging modalities. Radiologic findings are discussed according to disease stage, highlighting key diagnostic clues such as the zonal phenomenon and peripheral maturation pattern. In addition, the main entities included in the differential diagnosis are reviewed, with particular emphasis on imaging features that help distinguish myositis ossificans from soft-tissue sarcomas and other calcified or ossified lesions. Finally, current management strategies and the role of imaging in patient follow-up are summarized. A thorough understanding of the evolving imaging spectrum of myositis ossificans is essential for radiologists and clinicians to achieve an accurate diagnosis, guide appropriate management, and avoid overtreatment.

Indexed as

CTdifferential diagnosisheterotopic ossificationmimicsMRImyositis ossificanssoft tissue tumorsultrasoundzonal phenomenon

Identifiers

PMID42029569
PMCPMC13108044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.